InflaRx (IFRX) FCF Margin (QoQ) (2018 - 2026)
InflaRx (IFRX) FCF Margin (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.19 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.58 Bn | 77.59 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.34 Bn | 1.37 Bn |
| 4 | Moderna | 56.52 Bn | 51.38 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.04 Bn | 36.94 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.67 Bn | 27.36 Bn | 992.69 Mn |
| 7 | Insmed | 27.27 Bn | 26.11 Bn | 358.27 Mn |
| 8 | BioNTech SE | 27.14 Bn | 8.75 Bn | 668.28 Mn |
| 9 | Royalty Pharma | 27.12 Bn | 26.28 Bn | - |
| 10 | InflaRx | 137.27 Mn | -46.98 Mn | 2.74 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47,154.00 |
| Dec 31, 2025 | 3.76 Mn |
| Sep 30, 2025 | -1.84 Mn |
| Jun 30, 2025 | 1.97 Mn |
| Mar 31, 2025 | -3.88 Mn |
| Dec 31, 2024 | 777,710.00 |
| Sep 30, 2024 | 18.29 Mn |
| Jun 30, 2024 | -14.95 Mn |
| Mar 31, 2024 | -4.12 Mn |
| Dec 31, 2023 | -2,452.00 |
| Sep 30, 2023 | -67,105.00 |
| Jun 30, 2023 | 67,126.00 |
| Mar 31, 2023 | 152,451.00 |
| Dec 31, 2022 | -199,919.00 |
| Sep 30, 2022 | 55,859.00 |
| Jun 30, 2022 | -162,826.00 |
| Mar 31, 2022 | 154,396.00 |
| Dec 31, 2021 | -149,013.00 |
| Sep 30, 2021 | 154,638.00 |
| Jun 30, 2021 | -63,502.00 |